Literature DB >> 10746631

Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases.

M Dews1, M Prisco, F Peruzzi, G Romano, A Morrione, R Baserga.   

Abstract

The type 1 insulin-like growth factor receptor (IGF-IR) activates the extracellular signal-regulated kinases (ERK1 and -2). The two major substrates of the IGF-IR, insulin receptor substrate-1 (IRS-1) and the Shc proteins, are known to contribute to this activation. We investigated the domains of the IGF-IR required for the activation of the ERK proteins. To facilitate this study, we used a cell line (32D cells) that lacks IRS-1. In the absence of IRS-1, ERK activation is inhibited if the IGF-IR is mutated at two domains: tyrosine Y950 and a serine quartet at 1280-1283. Expression of IRS-1 in 32D cells expressing the double mutant IGF-IR restores ERK activation. The importance of the C-terminus of the IGF-IR in ERK activation (in the absence of IRS-1) is confirmed by the failure of the insulin receptor to give a sustained activation of ERK. In this model system, there is a good, but not exact, correlation between ERK activation and cell survival after withdrawal of growth factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10746631     DOI: 10.1210/endo.141.4.7414

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Regulation of Id gene expression by type I insulin-like growth factor: roles of Stat3 and the tyrosine 950 residue of the receptor.

Authors:  M Prisco; F Peruzzi; B Belletti; R Baserga
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Molecular and functional characterizations of the association and interactions between nucleophosmin-anaplastic lymphoma kinase and type I insulin-like growth factor receptor.

Authors:  Bin Shi; Deeksha Vishwamitra; J Gabrielle Granda; Thomas Whitton; Ping Shi; Hesham M Amin
Journal:  Neoplasia       Date:  2013-06       Impact factor: 5.715

3.  Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth.

Authors:  Deniz A Ucar; Elena Kurenova; Timothy J Garrett; William G Cance; Carl Nyberg; Audrey Cox; Nicole Massoll; David A Ostrov; Nicholas Lawrence; Said M Sebti; Maria Zajac-Kaye; Steven N Hochwald
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 4.  Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.

Authors:  Rongshi Li; Alan Pourpak; Stephan W Morris
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

5.  The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane.

Authors:  Robert X Song; Christopher J Barnes; Zhenguo Zhang; Yongde Bao; Rakesh Kumar; Richard J Santen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

6.  Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation.

Authors:  Julia I Leu; Mary Ann S Crissey; Linden E Craig; Rebecca Taub
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

7.  MAP Kinases and Prostate Cancer.

Authors:  Gonzalo Rodríguez-Berriguete; Benito Fraile; Pilar Martínez-Onsurbe; Gabriel Olmedilla; Ricardo Paniagua; Mar Royuela
Journal:  J Signal Transduct       Date:  2011-10-20

8.  Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.

Authors:  A Girnita; H Zheng; A Grönberg; L Girnita; M Ståhle
Journal:  Oncogene       Date:  2011-06-20       Impact factor: 9.867

9.  Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells.

Authors:  Marco Genua; Shi-Qiong Xu; Simone Buraschi; Stephen C Peiper; Leonard G Gomella; Antonino Belfiore; Renato V Iozzo; Andrea Morrione
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

Review 10.  Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation.

Authors:  Leonard Girnita; Claire Worrall; Shin-Ichiro Takahashi; Stefan Seregard; Ada Girnita
Journal:  Cell Mol Life Sci       Date:  2013-11-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.